Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that provides messenger RNA medicines. Valued at a market cap of $17.2 billion, the company gained global prominence with its COVID-19 vaccine and continues to expand its pipeline across infectious diseases, oncology, rare diseases, and autoimmune conditions. This biotechnology company has outperformed the broader market over the past 52 weeks. Shares of MRNA have rallied 19.3% over this time frame, while the broader S&P 500 I ...